换一批
换一批Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.
第一作者：
Daniel P,Cahill
第一单位：
Molecular Pathology Unit, Neurosurgical Service, Brain Tumor Center, and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
作者：
主题词
成年人(Adult);老年人(Aged);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);脑肿瘤(Brain Neoplasms);细胞增殖(Cell Proliferation);DNA修饰甲基酶类(DNA Modification Methylases);DNA修复酶类(DNA Repair Enzymes);DNA结合蛋白质类(DNA-Binding Proteins);达卡巴嗪(Dacarbazine);疾病恶化(Disease Progression);女(雌)性(Female);胶质母细胞瘤(Glioblastoma);人类(Humans);免疫组织化学(Immunohistochemistry);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);肿瘤复发, 局部(Neoplasm Recurrence, Local);聚合酶链反应(Polymerase Chain Reaction);肿瘤抑制蛋白质类(Tumor Suppressor Proteins)
DOI
10.1158/1078-0432.CCR-06-2149
PMID
17404084
发布时间
2023-05-22
- 浏览10
Clinical cancer research
2038-45页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
